ContraVir Pharmaceuticals (CTRV) Trading Up 8.8%
ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)’s share price was up 8.8% during trading on Monday . The company traded as high as $0.37 and last traded at $0.37. Approximately 515,420 shares traded hands during trading, a decline of 45% from the average daily volume of 935,219 shares. The stock had previously closed at $0.34.
Separately, Maxim Group reissued a “buy” rating and issued a $4.00 target price on shares of ContraVir Pharmaceuticals in a research report on Thursday, August 24th.
A hedge fund recently raised its stake in ContraVir Pharmaceuticals stock. Vanguard Group Inc. grew its holdings in ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) by 17.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,414,475 shares of the biopharmaceutical company’s stock after acquiring an additional 366,192 shares during the quarter. Vanguard Group Inc. owned 3.79% of ContraVir Pharmaceuticals worth $1,400,000 as of its most recent SEC filing. Institutional investors own 6.65% of the company’s stock.
About ContraVir Pharmaceuticals
Receive News & Ratings for ContraVir Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraVir Pharmaceuticals and related companies with Analyst Ratings Network's FREE daily email newsletter.